Can Wegovy Cause Muscle Aches — and What Should You Do About Them?

Step 1, Know what's actually in the prescribing information

Myalgia (the clinical term for muscle ache) appears in the Summary of Product Characteristics for Wegovy as an uncommon adverse reaction, which in regulatory language means it occurs in fewer than 1 in 100 people but more than 1 in 1,000. That places it well down the list compared with the gastrointestinal effects (nausea, diarrhoea, constipation and reflux) that are by far the most commonly reported experience when starting semaglutide.

The NHS medicines page for semaglutide groups muscle ache alongside headache and fatigue as side effects that some people notice, particularly early on. This reflects what the STEP 1 trial and subsequent real-world data have shown: a broad body adjustment phase in the first few weeks, not a specific attack on muscle tissue.

It is also worth understanding that semaglutide itself does not act on muscle cells directly. It is a GLP-1 receptor agonist, it works primarily through appetite regulation and slowing gastric emptying. Muscle discomfort is more likely a secondary effect of the overall adjustment your body makes when calorie intake drops sharply and energy balance shifts.

Step 2, Understand when aches tend to appear and why

Timing matters here. Muscle aches reported by people starting Wegovy most commonly cluster around two points: the first few weeks on the starter dose, and the period immediately after a dose increase. Both moments involve a step change in how the medicine is working, and both often settle within a week or two as the body finds its new baseline.

A related factor is food intake. When appetite falls significantly (which is the point of treatment) many people eat substantially less without being guided on protein targets or hydration. Muscle soreness can follow reduced protein intake, mild dehydration, or simply doing everyday activities while in a larger calorie deficit than the body is used to. These causes are addressable, not inevitable.

There is a distinct question about whether Wegovy causes muscle loss rather than just aches, and the two are not the same thing. Some data from the STEP trials suggested that a portion of weight lost during semaglutide treatment came from lean mass, as happens with most forms of significant weight loss. If that topic is something you want to read further on, the question of whether Wegovy causes muscle loss gets into the trial data in more detail.

Step 3, Separate aches that need attention from those that don't

Mild, diffuse muscle soreness that improves within a couple of weeks is generally consistent with the adjustment period described above. It does not usually require stopping treatment, and most prescribers would encourage patients to stay well hydrated, keep protein intake adequate, and remain active, including strength or resistance activity where possible.

Different symptoms deserve a different response. Severe muscle pain, pain that worsens rather than improves over time, weakness that affects your ability to move normally, or dark-coloured urine alongside muscle symptoms should all be assessed by a doctor promptly. These are not typical semaglutide side effects and may indicate a condition unrelated to your treatment, or, rarely, a drug interaction that needs reviewing.

The MHRA's Yellow Card scheme exists precisely for situations like this: if you experience a side effect that feels unexpected or serious, reporting it helps build the UK's post-market safety picture for all patients on these medicines. Your prescriber should always be your first call, but Yellow Card reporting is something any patient can do themselves.

If you are comparing whether muscle-related symptoms differ between Wegovy and other GLP-1 medicines, the semaglutide overview covers the broader side effect profile in context. For a closer look at the distinct question of leg discomfort specifically, whether Wegovy causes leg aches is worth reading alongside this page.

Step 4, What to ask your prescriber at your next review

Muscle aches that are mild and short-lived rarely need to change your treatment plan. The conversation worth having at your next clinical review is a practical one: are you eating enough protein relative to how much your appetite has fallen? Are you staying hydrated? Is there any resistance exercise built into your week that could help maintain lean mass during weight loss?

These are not abstract questions. Prescribers who oversee patients on semaglutide will typically explore lifestyle factors before concluding that aches are a direct medicine effect, because the indirect causes (protein gaps, dehydration, reduced activity) are fixable. A review of any other medicines you take is also worthwhile, since some combinations can increase muscle-related risk.

For people who are transferring from another provider or considering starting treatment, understanding how to access Wegovy in the UK through a regulated route matters for continuity of that kind of aftercare. A prescriber who reviews your case before every repeat order is the right safeguard here, not a one-time assessment and then silence. You can also read about body aches associated with Wegovy more broadly, since some patients find that generalised soreness, rather than localised muscle pain, is the experience they recognise.

If you are weighing up the cost of private treatment while managing side effect concerns, it may help to understand how Wegovy pricing works in the UK private market alongside what aftercare is actually included. The right setup means someone to call when questions like this arise, not just a medicine in the post.

If you would like a prescriber to review your situation directly, start a free consultation with our team and they will assess whether Wegovy is suitable for you and what monitoring makes sense at each stage.